The First AI-Designed Pandemic Vaccine Ends Empirical Immunology Forever

The pEVAC-PS vaccine trial marks a historic pivot from trial-and-error immunology to predictive, AI-driven engineering, proving that computer-simulated antigens can safely neutralize entire viral families. This breakthrough redefines global preparedness, shifting nations from reactive stockpiling to proactive, algorithmic defense against emerging pandemics.